Abbvie Inc
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.
Current Price
$212.30
-0.68%GoodMoat Value
$132.47
37.6% overvaluedProfile
Valuation (TTM)
Market Cap$375.38B
P/E103.27
EV$424.43B
P/B—
Shares Out1.77B
P/Sales5.98
Revenue$62.82B
EV/EBITDA26.36
Abbvie Inc (ABBV) — Earnings Call Transcripts
33 earnings call transcripts available.
Latest Transcript
Read →Q1 2026 Earnings Call
16 speakers10,404 words54 segments